Cargando…
Regulation of Glial Cell Functions by PPAR-γ Natural and Synthetic Agonists
In the recent years, the peroxisome proliferator-activated receptor-γ (PPAR-γ), a well known target for type II diabetes treatment, has received an increasing attention for its therapeutic potential in inflammatory and degenerative brain disorders. PPAR-γ agonists, which include naturally occurring...
Autores principales: | Bernardo, Antonietta, Minghetti, Luisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367430/ https://www.ncbi.nlm.nih.gov/pubmed/18464925 http://dx.doi.org/10.1155/2008/864140 |
Ejemplares similares
-
PPAR-γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2008) -
Curcumin promotes oligodendrocyte differentiation and their protection against TNF-α through the activation of the nuclear receptor PPAR-γ
por: Bernardo, Antonietta, et al.
Publicado: (2021) -
Therapeutic potential of PPARγ natural agonists in liver diseases
por: Wu, Liwei, et al.
Publicado: (2020) -
The Antihypertensive Drug Telmisartan Protects Oligodendrocytes from Cholesterol Accumulation and Promotes Differentiation by a PPAR-γ-Mediated Mechanism
por: Bernardo, Antonietta, et al.
Publicado: (2021) -
PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)